Third quarter 2026
- Sales of $25.0 billion, up 11 percent versus prior year, and up 12 percent organically*
- GAAP EPS of $1.89, including $0.26 of acquisition accounting adjustments and $0.11 of restructuring and other net significant and/or non-recurring items
- Adjusted EPS* of $2.26, up $0.56, or 33 percent, versus prior year, including $0.25 from IEEPA cost recovery
- Operating cash flow of $2.9 billion, including approximately $0.3 billion from IEEPA recovery; free cash flow* of $2.1 billion
- Company backlog of $340 billion, including $176 billion of commercial and $164 billion of defense
- Awarded Tomahawk and AMRAAM multi-year undefinitized production contracts in the third quarter
Updates outlook for full year 2026
You're not a member! Trial today
- Adjusted sales* of $97.0 – $97.5 billion, up from $95.0 – $96.0 billion
- Organic sales growth* of 10 to 11 percent, up from 8 to 9 percent
- Adjusted EPS* of $7.65 – $7.75, up from $7.10 – $7.25
- Free cash flow* of $9.0 – $9.2 billion, up from $8.50 – $8.75 billion
